{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:25:34Z","timestamp":1772504734289,"version":"3.50.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Painter Research Fund"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154985","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T17:51:09Z","timestamp":1463075469000},"page":"e0154985","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes"],"prefix":"10.1371","volume":"11","author":[{"given":"Kanwal","family":"Raghav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemendra","family":"Mhadgut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"McQuade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiudong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Matamoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Overman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauri R.","family":"Varadhachary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,5,12]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrc2349","article-title":"The distinctive biology of cancer in adolescents and young adults","volume":"8","author":"A Bleyer","year":"2008","journal-title":"Nature reviews Cancer"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.6004\/jnccn.2014.0004","article-title":"Adolescent and young adult oncology, version 2.2014","volume":"12","author":"PF Coccia","year":"2014","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"key":"ref3","article-title":"Insurance status and risk of cancer mortality among adolescents and young adults","author":"AR Rosenberg","year":"2014","journal-title":"Cancer"},{"issue":"30","key":"ref4","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1200\/JCO.2011.36.2954","article-title":"Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?","volume":"29","author":"HM Parsons","year":"2011","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.seminoncol.2009.07.004","article-title":"Relative lack of conditional survival improvement in young adults with cancer","volume":"36","author":"A Bleyer","year":"2009","journal-title":"Seminars in oncology"},{"key":"ref6","unstructured":"NIH-NCI LYAA. Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer: Report of the Adolescent and Young Adult Oncology Progress Review Group 2006 [updated 20068th March 2015]. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES: National Institutes of Health &amp; National Cancer Institute and LIVESTRONG<sup>\u2122<\/sup> Young Adult Alliance]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/planning.cancer.gov\/library\/AYAO_PRG_Report_2006_FINAL.pdf\" xlink:type=\"simple\">http:\/\/planning.cancer.gov\/library\/AYAO_PRG_Report_2006_FINAL.pdf<\/ext-link>."},{"issue":"21","key":"ref7","first-page":"2040","article-title":"Carcinoma of unknown primary site","volume":"371","author":"GR Varadhachary","year":"2014","journal-title":"The New England journal of medicine"},{"issue":"9824","key":"ref8","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","article-title":"Cancer of unknown primary site","volume":"379","author":"N Pavlidis","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1200\/JCO.2012.43.3755","article-title":"Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute","volume":"31","author":"JD Hainsworth","year":"2013","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"27","key":"ref10","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1200\/JCO.2013.54.9329","article-title":"Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program","volume":"32","author":"CH Lieu","year":"2014","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"24","key":"ref11","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1200\/JCO.2002.04.019","article-title":"Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site","volume":"20","author":"S Culine","year":"2002","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/PPO.0b013e3181c6aa89","article-title":"Paclitaxel\/carboplatin\/etoposide versus gemcitabine\/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial","volume":"16","author":"JD Hainsworth","year":"2010","journal-title":"Cancer journal"},{"key":"ref13","article-title":"Paclitaxel\/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial","author":"JD Hainsworth","year":"2015","journal-title":"Cancer"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.6004\/jnccn.2011.0119","article-title":"Carcinoma of unknown primary: focused evaluation","volume":"9","author":"GR Varadhachary","year":"2011","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1158\/1078-0432.CCR-10-2599","article-title":"Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary","volume":"17","author":"GR Varadhachary","year":"2011","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1634\/theoncologist.2009-0328","article-title":"Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction","volume":"15","author":"FA Greco","year":"2010","journal-title":"The oncologist"},{"issue":"15","key":"ref17","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1158\/1078-0432.CCR-12-3030","article-title":"New strategies for carcinoma of unknown primary: the role of tissue-of-origin molecular profiling","volume":"19","author":"G Varadhachary","year":"2013","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40291-015-0133-8","article-title":"Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay","volume":"19","author":"FA Greco","year":"2015","journal-title":"Molecular diagnosis & therapy"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jnci\/djt099","article-title":"Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology","volume":"105","author":"FA Greco","year":"2013","journal-title":"Journal of the National Cancer Institute"},{"key":"ref20","unstructured":"NCCN. Occult Primary (Cancer of Unknown Primary) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)2015. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/occult.pdf\" xlink:type=\"simple\">http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/occult.pdf<\/ext-link>."},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10585-014-9666-1","article-title":"Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group","volume":"31","author":"G Pentheroudakis","year":"2014","journal-title":"Clinical & experimental metastasis"},{"issue":"6B","key":"ref22","first-page":"2563","article-title":"Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin","volume":"15","author":"N Pavlidis","year":"1995","journal-title":"Anticancer Res"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamaoncol.2014.216","article-title":"Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies","volume":"1","author":"JS Ross","year":"2015","journal-title":"JAMA oncology"},{"issue":"7 Suppl","key":"ref24","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/cncr.22102","article-title":"Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials","volume":"107","author":"A Bleyer","year":"2006","journal-title":"Cancer"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/cncr.20995","article-title":"National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation","volume":"103","author":"A Bleyer","year":"2005","journal-title":"Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:47:44Z","timestamp":1589003264000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154985"}},"subtitle":[],"editor":[{"given":"Andreas","family":"Krieg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,12]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154985","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,12]]}}}